Aleksandr Lazaryan

26PUBLICATIONS
188CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 21, 2026
Chronic graft vs. host disease following post-transplant cyclophosphamide (PTCy) based prophylaxis vs. non-PTCy prophylaxis.

|Jul 17, 2026
A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma.

|Jun 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD prevention.

|May 20, 2026
Absolute risk trade-offs of donor age, sex, and graft source in PTCy-based transplantation.

|Apr 15, 2026
Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age.

|Apr 08, 2026
Single center evaluation of a composite risk assessment model to predict non-relapse mortality following allogeneic hematopoietic cell transplantation (HCT).

Reshma Ramlal, Jongphil Kim, Zachary Thompson

Pageof 5

Frequent Collaborators

13 joint publications

Taiga Nishihori

10 joint publications

Michael Jain

9 joint publications

Nelli Bejanyan

7 joint publications

Marco L Davila